| Literature DB >> 27624340 |
Chunrong Gu1, Hengfang Wu2, Gaoyuan Ge1,2, Xiongzhi Li1, Zhirui Guo3, Zhiping Bian1, Jindan Xu2, Hua Lu4, Xiangjian Chen5, Di Yang6.
Abstract
Gold nanoparticles are emerging as promising biomedical tools due to their unique nanoscale characteristics. Our purpose was to synthesize a hollow-shaped gold nanoparticle and to investigate its effect on human aortic endothelial cells (HAECs) in vitro. Hollow gold nanoshells with average 35-nm diameters and 10-nm shell thickness were obtained by galvanic replacement using quasi-spherical nanosilver as sacrifice-template. Our results showed that hollow gold nanoshells in the culture medium could be internalized into the cytoplasm of HAECs. No cytotoxicity effect of hollow gold nanoshells on HAECs was observed within the test concentrations (0-0.8 μg/mL) and test exposure period (0-72 h) by tetrazolium dye assay. Meanwhile, the release of cell injury biomarker, lactate dehydrogenase, was not significantly higher than that from control cells (without hollow gold nanoshells). The concentrations of vasodilators, nitric oxide, and prostacyclin I-2 were not changed, but the vasoconstrictor endothelin-1 was decreased by hollow gold nanoshells treatment in HAECs. HAECs exposed to hollow gold nanoshells resulted in suppressing expressions of genes involved in apoptosis and activating expressions of genes of adhesion molecules. Moreover, we demonstrated by in vitro endothelial tube formation that hollow gold nanoshells (0.8 μg/mL) could not inhibit angiogenesis by the HAECs. Altogether, these results indicate that the structure and major function of HAECs would not be disrupted by hollow gold nanoshell treatment.Entities:
Keywords: Angiogenesis; Cell viability; Hollow gold nanoshells; Human aortic endothelial cells
Year: 2016 PMID: 27624340 PMCID: PMC5021651 DOI: 10.1186/s11671-016-1620-5
Source DB: PubMed Journal: Nanoscale Res Lett ISSN: 1556-276X Impact factor: 4.703
Fig. 1a The SEM image of as-obtained hollow gold nanoshells. Inset shows the image of these nanoshells at large magnification. b UV-vis spectra of (a) Ag nanoparticles solution (b) hollow gold nanoshells solution. Insets shows corresponding electronic pictures of (c) Ag nanoparticles solution and (d) hollow gold nanoshells solution
Fig. 2The TEM images of HAECs incubated with hollow gold nanoshells for 24 h. a, b HAEC without hollow gold nanoshells. c, d HAEC incubated with hollow gold nanoshells. The scale bars indicate 2 μm in a and c and 0.5 μm in b and d. n nucleus. Arrows denote the hollow gold nanoshells or particulate matter
Fig. 3The cell viability of HAECs incubated with hollow gold nanoshells. Data are expressed as mean ± SD from independent experiments. Control values from HAECs incubated without hollow gold nanoshells were defined as 1. a HAECs were incubated with DMEM containing the gradient concentrations of hollow gold nanoshells for 24 h (0.008 to 0.8 μg/mL). b HAECs were incubated with DMEM containing 0.8 μg/mL hollow gold nanoshells for the indicated times (4, 24, 48, 72 h). *p < 0.05 vs. control
Fig. 4The levels of injury marker, LDH, and vasoregulators in supernatant. The HAECs were incubated with 0.8 μg/mL hollow gold nanoshells for 24 h. Ratios relative to control cells (without hollow gold nanoshells) are shown. *p < 0.05 vs. control; **p < 0.01 vs. control
Fig. 5The fold changes in genes expression in HAECs incubated with hollow gold nanoshells. The results were analyzed by the 2−ΔΔCT method. Gene symbols and corresponding encoded proteins: MAP3K5 apoptosis signal-regulating kinase 1 (ASK1), TRAF2 tumor necrosis factor receptor-associated factor 2 (TRAF2), DAB2IP ASK1-interacting protein (AIP1), MAPK8 mitogen-activated protein kinase 8 (JNK1), MAPK9 mitogen-activated protein kinase 9 (JNK2), MAPK14 mitogen-activated protein kinase 14 (p38 MAPK α), ERN1 endoplasmic reticulum to nucleus signaling 1 (IRE1), BCL2 B cell lymphoma 2 (Bcl-2), BAX Bcl-2-associated X protein (Bax), NKRF nuclear factor Kb repressing factor, TXN thioredoxin, CTSB cathespin B, CYCS cytochrome C, CASP9 caspase-9, CASP3 caspase-3, EIF2AK3 eukaryotic translation initiation factor 2α kinase 3 (PERK), ATF4 activating transcription factor 4, DDIT3 DNA-damage-inducible transcript 3 (CHOP), EIF2A eukaryotic translation initiation factor 2α, NOS3 nitric oxide synthase 3 (eNOS), SOD1 super oxide dismutase 1 (SOD-1), SOD2 super oxide dismutase 2 (SOD-2), ROMO1 reactive oxygen species modulator 1, PTGS1 cyclooxygenase 1 (COX-1), PTGS2 cyclooxygenase 2 (COX-2), VCAM1 vascular cell adhesion molecule 1 (VCAM-1), ICAM1 intercellular adhesion molecule 1 (ICAM-1), ICAM2 intercellular adhesion molecule 2 (ICAM-2), SELE endothelial-leukocyte adhesion molecule 1 (E-selectin), PLCG1 phospholipase C γ1, PLCG2 phospholipase C γ2, ITPR1 inositol 1,4,5-trisphosphate receptor type 1 (IP3R1), ITPR2 inositol 1,4,5-trisphosphate receptor type 2 (IP3R2), ITPR3 inositol 1,4,5-trisphosphate receptor type 3 (IP3R3), CALM1 calmodulin 1 (CAM1)
Fig. 6Effect of hollow gold nanoshells on tube network formed by HAECs cultured on Matrigel within 14 h. a HAECs can form a capillary-like network on Matrigel-coated wells within 14 h. b No obvious change to form networks by HAECs in the presence of 0.8 μg/mL hollow gold nanoshells. c The high urea solution (6 M urea) was used as a positive control for inhibition of tube formation